Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

about

Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

Item

http://www.wikidata.org/entity/Q58759112

description

scientific article published on 01 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

@en

Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

@nl

type

Item

label

Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

@en

Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

@nl

prefLabel

Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

@en

Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

@nl

P1476

Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

@en

P2093

Adel Kardosh

http://www.w3.org/2001/XMLSchema#string

Sophie Robinson

http://www.w3.org/2001/XMLSchema#string

P2860

Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.

Building of the tetraspanin web: distinct structural domains of CD81 function in different cellular compartments.

STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer

Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK

Ibrutinib enhances the antitumor immune response induced by intratumoral injection of a TLR9 ligand in mouse lymphoma

STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.

T-cell exhaustion in the tumor microenvironment.

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.

STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.

P304

2230-2241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOODADVANCES.2018020040

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ronald Levy

Adrienne Sallets

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30194137

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

6134215

http://www.w3.org/2001/XMLSchema#string